| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |